H
Heather Milburn
Researcher at Guy's and St Thomas' NHS Foundation Trust
Publications - 37
Citations - 3878
Heather Milburn is an academic researcher from Guy's and St Thomas' NHS Foundation Trust. The author has contributed to research in topics: Tuberculosis & Latent tuberculosis. The author has an hindex of 17, co-authored 37 publications receiving 3411 citations. Previous affiliations of Heather Milburn include University of London & King's College London.
Papers
More filters
Journal ArticleDOI
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
Wouter Hoefsloot,Jakko van Ingen,Claire Andrejak,Kristian Ängeby,Rosine Bauriaud,Pascale Bémer,Natalie Beylis,Martin J. Boeree,Juana Cacho,Violet N. Chihota,Erica Chimara,Gavin J. Churchyard,Raquel Cias,Rosa Daza,Charles L. Daley,P. N. Richard Dekhuijzen,Diego Domingo,Francis Drobniewski,Jaime Esteban,Maryse Fauville-Dufaux,Dorte Bek Folkvardsen,Noel Gibbons,Enrique Gómez-Mampaso,Rosa Gonzalez,Harald Hoffmann,Po-Ren Hsueh,Alexander Indra,Tomasz Jagielski,Frances Jamieson,Mateja Janković,Eefje Jong,Joseph Keane,Wo Jung Koh,Berit Lange,Sylvia Cardoso Leão,Rita Macedo,Turid Mannsåker,Theodore K. Marras,Jeannette Maugein,Heather Milburn,Tamas Mlinkó,Nora Morcillo,Kozo Morimoto,Dimitrios Papaventsis,Elia Palenque,Mar Paez-Peña,Claudio Piersimoni,Monika Polanova,Nalin Rastogi,Elvira Richter,Maria Jesus Ruiz-Serrano,Anabela Santos Silva,M. Pedro Da Silva,M. Pedro Da Silva,Hülya Şimşek,Dick van Soolingen,Nora Szabó,Rachel Thomson,Teresa Fernandez,Enrico Tortoli,Sarah E. Totten,Greg Tyrrell,Tuula Vasankari,Miguel Villar,Renata Walkiewicz,Kevin L. Winthrop,Dirk Wagner +66 more
TL;DR: A snapshot of NTM species distribution demonstrates that the species distribution among NTM isolates from pulmonary specimens in the year 2008 differed by continent and differed by country within these continents.
Journal ArticleDOI
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.
Ulrich Mack,Giovanni Battista Migliori,Martina Sester,Hans L. Rieder,Stefan Ehlers,Delia Goletti,Aik Bossink,Klaus Magdorf,Christoph Hölscher,Beate Kampmann,S. M. Arend,A Detjen,Graham H. Bothamley,Jean-Pierre Zellweger,Heather Milburn,Roland Diel,Pernille Ravn,Frank Cobelens,P J Cardona,B Kan,Ivan Solovic,Raquel Duarte,Daniela Maria Cirillo +22 more
TL;DR: The main issue regarding testing is to restrict it to those who are known to be at higher risk of developing tuberculosis and who are willing to accept preventive chemotherapy, and to identify an adaptive immune response against, but not necessarily a latent infection with, M. tuberculosis.
Journal ArticleDOI
High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.
Adrian R. Martineau,Adrian R. Martineau,Peter Timms,Graham H. Bothamley,Yasmeen Hanifa,Kamrul Islam,Alleyna P. Claxton,Geoffrey E. Packe,John Moore-Gillon,Mathina Darmalingam,Robert N. Davidson,Heather Milburn,L V Baker,Richard D. Barker,Nicholas Woodward,Timothy R Venton,Korina E. Barnes,Christopher J Mullett,Anna K. Coussens,Clare Rutterford,Charles A. Mein,Geraint Davies,Robert J. Wilkinson,Vladyslav Nikolayevskyy,Francis Drobniewski,Sandra Eldridge,Chris Griffiths +26 more
TL;DR: In this article, a multicentre randomised controlled trial of adjunctive vitamin D in adults with sputum smear-positive pulmonary tuberculosis in London, UK was conducted.
Journal ArticleDOI
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Charles S. Haworth,John Banks,Toby Capstick,Andrew J. Fisher,Thomas Gorsuch,Ian F. Laurenson,Andrew R. Leitch,Michael R. Loebinger,Heather Milburn,Mark Nightingale,Peter Ormerod,Delane Shingadia,David Smith,Nuala Whitehead,Robert Wilson,R. Andres Floto,R. Andres Floto +16 more
TL;DR: Recommendations and recommendations on what samples should be used to detect pulmonary non-tuberculous mycobacterial infection and how to define lung disease attributable to NTM infection are presented.
Journal ArticleDOI
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Ivan Solovic,Martina Sester,Juan J. Gomez-Reino,Hans L. Rieder,Stefan Ehlers,Heather Milburn,Beate Kampmann,Bernhard Hellmich,Richard Groves,Stefan Schreiber,Robert S. Wallis,Giovanni Sotgiu,E. H. Scholvinck,Delia Goletti,Jean-Pierre Zellweger,Roland Diel,Loreto Carmona,Filippo Bartalesi,Pernille Ravn,Aik Bossink,Raquel Duarte,Connie Erkens,Julia E Clark,Giovanni Battista Migliori,Christoph Lange +24 more
TL;DR: The TBNET consensus statement as discussed by the authors summarises current knowledge and expert opinions and provides evidence-based recommendations to reduce the TB risk among candidates for TNF antagonist therapy, which significantly reduces the risk of progression to TB.